In-depth analysis and the latest news on retail estate alternatives: data centres, healthcare, hotels, leisure, life sciences, self-storage and student housing
Reshoring is creating new markets for US biomanufacturing. Virna Asara reports
The growing interplay between life sciences and technology is spawning new innovation districts amid a changing environment for the biopharma sector
Asia-Pacific’s life sciences real estate market has historically been dominated by a few – mainly local – players, but that is starting to change
The world’s largest real estate multi-manager, which was very active in 2025, is now part of a broader alternatives platform
Future Growth Capital has agreed a £20m senior loan to nLighten
The investment comes as Maryland SRPS cuts real estate target allocation from 10% to 9%
SCOR Real Estate Loans V attracted capital from both existing and new institutional investors
Owner and developer of hospitals achieves Malaysia’s largest listing in a decade
SCOR Real Estate Loans V attracted capital from both existing and new institutional investors
Joint venture will target loans of £20m to £75m to fund best-in-class projects in the residential, BTR and PBSA sectors
Future Growth Capital has agreed a £20m senior loan to nLighten
This investment has been placed by the pension fund as part of its real assets portfolio
Owner and developer of hospitals achieves Malaysia’s largest listing in a decade
Medical outpatient venture with a global institutional investor exceeds $550m deployment
Company plans to add 20 new properties and more than 1,400 rooms across Spain, Italy, Portugal and the UK
NZ Hotel Holdings sells Wellington and Queenstown hotels
SCOR Real Estate Loans V attracted capital from both existing and new institutional investors
Reshoring is creating new markets for US biomanufacturing. Virna Asara reports
All-share deal creates a combined entity with $77bn enterprise value
Transaction forms part of Ardian’s strategy to grow its pan-European self-storage platform
Sale of Lodgyslife delivered a 32.5% gross internal rate of return
Redevco sells asset in London’s Southbank for unspecified sum